1251. 5-year outcomes of bictegravir/emtricitabine/tenofovir alafenamide (B/F/TAF) as initial treatment of HIV-1 in adults with high baseline HIV-1 RNA and/or low CD4 count in two...

por Ramgopal, Moti, Wurapa, Anson, Baumgarten, Axel, Berhe, Mezgebe, Pozniak, Anton, Orkin, Chloe, Tiraboschi, Juan Manuel, Hagins, Debbie P, Huang, Hailin, Andreatta, Kristin, Unger, Nathan, Hindman, Jason, Martin, Hal, Baeten, Jared, Osiyemi, Olayemi
Publicado 2022